Company intelligence / Profile preview

Metronom Health

Laguna Hills, California, United Statesmetronomhealth.com ↗

Ownership: Private
Employees: ~22
Development stage: Preclinical

Overview

Metronom Health is developing a minimally invasive continuous glucose monitoring system using proprietary opto-enzymatic technology. Preliminary results suggest high accuracy across a wide range of glucose levels, with the sensor designed to last up to 14 days and reduce patient discomfort and infection risk. The company aims for an industry-leading cost profile to enable broader adoption[1][2].

Therapeutic areas: Endocrinology
Modalities: DeviceDiagnostic device (Continuous Glucose Monitoring)Opto-enzymatic technology platform (for glucose sensing)
Industry: Physiological Monitoring

Partnerships

Dinova Medtech (joint venture for China market development)[2]

Beyond the preview

Go deeper on Metronom Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metronom Health.

Explore the full profile